DK0406211T3 - Fucosidase-inhibitorer - Google Patents
Fucosidase-inhibitorerInfo
- Publication number
- DK0406211T3 DK0406211T3 DK90870105.5T DK90870105T DK0406211T3 DK 0406211 T3 DK0406211 T3 DK 0406211T3 DK 90870105 T DK90870105 T DK 90870105T DK 0406211 T3 DK0406211 T3 DK 0406211T3
- Authority
- DK
- Denmark
- Prior art keywords
- fucosidase inhibitors
- inhibitors
- beta
- fucosidase
- homofuconojirimycin
- Prior art date
Links
- 102000012086 alpha-L-Fucosidase Human genes 0.000 title abstract 2
- 108010061314 alpha-L-Fucosidase Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- DCVWZPYTNWZZIM-UHFFFAOYSA-N alpha-7-deoxyhomonojirimycin Natural products CC1NC(CO)C(O)CC1O DCVWZPYTNWZZIM-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/371,943 US5100797A (en) | 1989-06-27 | 1989-06-27 | Fucosidase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0406211T3 true DK0406211T3 (da) | 1994-05-02 |
Family
ID=23466049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90870105.5T DK0406211T3 (da) | 1989-06-27 | 1990-06-26 | Fucosidase-inhibitorer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5100797A (da) |
| EP (1) | EP0406211B1 (da) |
| JP (1) | JP2927893B2 (da) |
| AT (1) | ATE103594T1 (da) |
| CA (1) | CA2019798C (da) |
| DE (1) | DE69007695T2 (da) |
| DK (1) | DK0406211T3 (da) |
| ES (1) | ES2063329T3 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992021657A1 (en) * | 1991-05-30 | 1992-12-10 | The Scripps Research Institute | Omega-deoxy-azasugars |
| US5276120A (en) * | 1991-05-30 | 1994-01-04 | The Scripps Research Institute | Process for forming omega-deuxy-azasugars |
| US6610709B1 (en) * | 1999-02-02 | 2003-08-26 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof |
| EP1210082B1 (en) * | 1999-08-10 | 2008-01-02 | The Chancellor, Masters And Scholars Of The University Of Oxford | Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
| EP2049126A2 (en) * | 2006-08-02 | 2009-04-22 | United Therapeutics Corporation | Liposome treatment of viral infections |
| CA2666814A1 (en) * | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
| CN102046151A (zh) * | 2008-03-26 | 2011-05-04 | 牛津大学 | 靶向内质网的脂质体 |
| JP2012521981A (ja) * | 2009-03-27 | 2012-09-20 | ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード | コレステロールレベル低下リポソーム |
| CN102905716B (zh) | 2010-01-28 | 2016-06-01 | 雷普特制药公司 | 以受体相关蛋白(rap)肽-岩藻糖苷酶抑制剂偶联物治疗肝病症的方法 |
| JP6981961B2 (ja) | 2015-07-30 | 2021-12-17 | ホライズン オルファン エルエルシー | フコシダーゼ阻害剤 |
| CN112843081B (zh) * | 2021-02-02 | 2022-07-05 | 四川大学 | 一种dna四面体-白藜芦醇复合物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| DE2848117A1 (de) * | 1978-11-06 | 1980-05-14 | Bayer Ag | Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels |
| DE3814549A1 (de) * | 1987-10-30 | 1989-05-18 | Bayer Ag | N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln |
| DE3737523A1 (de) * | 1987-11-05 | 1989-05-18 | Bayer Ag | Verwendung von substituierten hydroxypiperidinen als antivirale mittel |
| US4999360A (en) * | 1987-12-21 | 1991-03-12 | Monsanto Company | Method of inhibiting virus |
| US4849430A (en) * | 1988-03-09 | 1989-07-18 | Monsanto Company | Method of inhibiting virus |
| US4861892A (en) * | 1988-02-12 | 1989-08-29 | G. D. Searle & Co. | Method for synthesis of deoxymannojirimycin |
| US4992460A (en) * | 1989-09-08 | 1991-02-12 | Monsanto Company | Bicyclic tetrahydroxylated pyrrolizidines |
| US4996329A (en) * | 1989-10-20 | 1991-02-26 | Monsanto Company | Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation |
-
1989
- 1989-06-27 US US07/371,943 patent/US5100797A/en not_active Expired - Lifetime
-
1990
- 1990-06-26 ES ES90870105T patent/ES2063329T3/es not_active Expired - Lifetime
- 1990-06-26 DE DE69007695T patent/DE69007695T2/de not_active Expired - Fee Related
- 1990-06-26 DK DK90870105.5T patent/DK0406211T3/da active
- 1990-06-26 AT AT90870105T patent/ATE103594T1/de not_active IP Right Cessation
- 1990-06-26 JP JP2165886A patent/JP2927893B2/ja not_active Expired - Fee Related
- 1990-06-26 CA CA002019798A patent/CA2019798C/en not_active Expired - Fee Related
- 1990-06-26 EP EP90870105A patent/EP0406211B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007695T2 (de) | 1994-08-11 |
| CA2019798C (en) | 2001-03-20 |
| ATE103594T1 (de) | 1994-04-15 |
| ES2063329T3 (es) | 1995-01-01 |
| JPH0331260A (ja) | 1991-02-12 |
| US5100797A (en) | 1992-03-31 |
| DE69007695D1 (de) | 1994-05-05 |
| EP0406211B1 (en) | 1994-03-30 |
| EP0406211A2 (en) | 1991-01-02 |
| EP0406211A3 (en) | 1991-05-08 |
| CA2019798A1 (en) | 1990-12-27 |
| JP2927893B2 (ja) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0337713A3 (en) | 2-substituted-4-substituted-1,3-dioxolanes, synthesis and use thereof | |
| FI894671A (fi) | Reglerbar faestanordning. | |
| NO904210L (no) | Syntese av hydrokarbylaminer. | |
| MX9203768A (es) | Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a. | |
| DE69007695D1 (de) | Fucosidase-Inhibitoren. | |
| FI890393A0 (fi) | Foerfarande foer framstaellning av isokinoliner. | |
| PT545511E (pt) | Processo para a preparacao de tetraazamacrociclos mono-n-substituidos | |
| NO890483L (no) | Framgangsmaate for tilvirkning av formlegemer. | |
| NO903303D0 (no) | Fremgangsmaate for syntese av alfa-hydroksyketoner. | |
| FI904676A0 (fi) | Anordning foer loesgoerande av manteln i en haeftapparat. | |
| IT8622467A0 (it) | Procedimento per la sintesi di perfluoroalcadieni. | |
| FI940165A0 (fi) | 2-fenyylisubstituoitujen 1,3-propaanidiolien synteesi | |
| FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
| ATE132500T1 (de) | 24r-scymnol, herstellung und verwendung | |
| ES2023930B3 (es) | Sintesis de ditioles. | |
| DE59004528D1 (de) | Verwendung des (+)-enantiomeren von anipamil. | |
| FI913285A (fi) | Svavelsubstituerade mevinsyraderivat. | |
| ES2019251A4 (es) | Produccion de alfa-cloro-alfa-oximino-4-hidroxilo acetofenona. | |
| SU1690242A1 (ru) | Антифидант | |
| IT8922867A0 (it) | Sintesi del carbanione 1,1,2-triciano-2-(3,4-diciano-5-immino-2,5- diidro-1h-pirrol-2-ilidene) etanuro | |
| DK51893D0 (da) | 1,2,3-thiadiazol-4-thio-forbindelser | |
| SU1610823A1 (ru) | S-трет-бутилтиуронийбромид, обладающий антиишемической активностью | |
| UA11675A1 (uk) | 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ | |
| ATE101038T1 (de) | Verwendung des (+)-enantiomeren von anipamil. | |
| FI906144A0 (fi) | Modifiering av plasminogenaktivatorer. |